Clinical trial
A Multicenter, Double-Blind, Randomized, Placebo-Controlled, Parallel-Group Study to Assess the Pharmacodynamics of Lemborexant in Korean Subjects With Insomnia Disorder
NCT05594589 is registered in ClinicalTrials.gov with Eisai Co., Ltd. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Multicenter, Double-Blind, Randomized, Placebo-Controlled, Parallel-Group Study to Assess the Pharmacodynamics of Lemborexant in Korean Subjects With Insomnia Disorder
- Lead sponsor
- Eisai Co., Ltd.
- Phase
- Phase 2
- Overall status
- Completed
- Start date
- November 30, 2022
- Completion date
- May 24, 2024
- Enrollment
- 65 (actual)
- Sites
- 9
Conditions
As the registry lists them; a condition with its own page is linked.